Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

The End of Silo Medicine: A Case for Disease-Centered Subspecialization.

Created on 28 Jul 2026

Authors

Thomas Hegyi, Robert J Ostfeld

Published in

Journal of evaluation in clinical practice. Volume 32. Issue 5. Pages e70542.

Abstract

Modern medical subspecialization was organized around organs, age groups and procedures during an era when diseases were viewed as isolated processes. Contemporary biology instead reveals illnesses that arise across systems and evolve across the life span. Yet clinical care remains fragmented among multiple specialties with no single physician accountable for the integrated whole. We propose disease-centred subspecialization, in which expertise for a complex condition is unified within a single clinical domain and supported by advanced clinical intelligence systems. Fetoneonatology, integrating foetal and neonatal medicine across the continuum of pregnancy and early life, illustrates this model. Similar integration is urgently needed for metabolic syndrome and ischaemic heart disease, conditions whose pathophysiology spans multiple organs and specialties. Evidence increasingly shows that fragmented care contributes to medical error, contradictory treatment plans, rehospitalization and poor long-term outcomes. We outline a framework for training, certification and AI augmented practice, organized around diseases rather than anatomy alone.

PMID:
42507817
Bibliographic data and abstract were imported from PubMed on 28 Jul 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 3
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement